Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Schumacher

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 10, 2006
Early morning blood pressure surgePhilippe Gosse, Helmut Schumacher
Blood Pressure. Supplement|August 19, 2008
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studiesHelmut Schumacher, Giuseppe Mancia
Patient Preference and Adherence|January 25, 2012
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trialsGiuseppe Mancia, Helmut Schumacher
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 6, 2013
Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combinationGianfranco Parati, Helmut Schumacher
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 20, 2013
Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studiesPhilippe Gosse, Helmut Schumacher
Current Medical Research and Opinion|November 20, 2012
Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)Ludwin Ley, Helmut Schumacher
Expert Opinion on Pharmacotherapy|October 12, 2012
Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertensionL M Ruilope, Helmut Schumacher
International Journal of Hypertension|July 12, 2013
Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB MonotherapySteen Neldam, Dingliang Zhu, Helmut Schumacher
Advances in Therapy|April 6, 2012
Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressuresSteen Neldam, Helmut Schumacher, Robert Guthrie
Lancet (London, England)|December 13, 2017
Overestimation of cardiovascular outcome incidence - Authors' replyHelmut Schumacher, Felix Mahfoud, Michael Böhm
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Hypertension (Greenwich, Conn.)|August 10, 2006
Early morning blood pressure surgePhilippe Gosse, Helmut Schumacher
Blood Pressure. Supplement|August 19, 2008
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studiesHelmut Schumacher, Giuseppe Mancia
Patient Preference and Adherence|January 25, 2012
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trialsGiuseppe Mancia, Helmut Schumacher
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 6, 2013
Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combinationGianfranco Parati, Helmut Schumacher
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 20, 2013
Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studiesPhilippe Gosse, Helmut Schumacher
Current Medical Research and Opinion|November 20, 2012
Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)Ludwin Ley, Helmut Schumacher
Expert Opinion on Pharmacotherapy|October 12, 2012
Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertensionL M Ruilope, Helmut Schumacher
International Journal of Hypertension|July 12, 2013
Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB MonotherapySteen Neldam, Dingliang Zhu, Helmut Schumacher
Advances in Therapy|April 6, 2012
Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressuresSteen Neldam, Helmut Schumacher, Robert Guthrie
Lancet (London, England)|December 13, 2017
Overestimation of cardiovascular outcome incidence - Authors' replyHelmut Schumacher, Felix Mahfoud, Michael Böhm
Pageof 8